Recombinant Human IL-35 Fc Chimera Protein, CF 8608-IL-050 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemRecombinant Human IL-35 Fc Chimera Protein, CF
CompanyR&D Systems, a Bio-Techne Brand
Price $408.00Supplier Page View Company Product Page
Catalog Number8608-IL-050
Size50 ug
ApplicationsBioactivity
FormatLyophilized from a 0.2 µm filtered solution in PBS
Purity>80%, by SDS-PAGE under reducing conditions and visualized by silver stain
Molecular WeightObserved: 81-97 kDa, reducing conditions
Theoretical: 73 kDa
Conjugate/TagUnconjugated
SpeciesHuman
Molecule NameIL-35
Source/Expression SystemHEK293-derived Recombinant Human IL-35 Fc Chimera Protein, CF
NCBI Full Gene NameABL proto-oncogene 2, non-receptor tyrosine kinase, interleukin 12A, Epstein-Barr virus induced 3, serpin family A member 3, aldehyde dehydrogenase 9 family member A1
NCBI Gene AliasesACT, IL35B, CLMF, ABLL, IL27B, ALDH4, NKSF1, NFSK, ALDH7, P35, GIG24, GIG25, ALDH9, TMABA-DH, TMABADH, ARG, IL-27B, IL-12A, TMABALDH, E3, AACT
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) IL-35 ameliorates lipopolysaccharide-induced endothelial dysfunction by inhibiting endothelial-to-mesenchymal transitionInternational immunopharmacologyMarch 10, 2024Feng J, Li K, Xie F, Han L, Wu Y.

(2) At Embryo Implantation Site IL-35 Secreted by Trophoblast, Polarizing T Cells towards IL-35+ IL-10+ IL-4+ Th2-Type Cells, Could Favour Fetal Allograft Tolerance and Pregnancy SuccessInternational journal of molecular sciencesApril 28, 2022Lombardelli L, Logiodice F, Kullolli O, Haller H, Agostinis C, Bulla R, Rukavina D, Piccinni MP.

(3) IL-35 is critical in suppressing superantigenic Staphylococcus aureus-driven inflammatory Th17 responses in human nasopharynx-associated lymphoid tissueMucosal immunologyMay 1, 2020Xu R, Shears RK, Sharma R, Krishna M, Webb C, Ali R, Wei X, Kadioglu A, Zhang Q.

(4) IL-37- and IL-35/IL-37-Producing Plasma Cells in Chronic PeriodontitisJournal of Dental ResearchJuly 1, 2019L. Jing, S. Kim, L. Sun, L. Wang, E. Mildner, K. Divaris, Y. Jiao, S. Offenbacherperiodontitis. Immunohistochemistry and Quantification Materials and Methods rhIL-35 was purchased (8608-IL-050; R&D Systems) and reconstituted into sterile phosphate-buffered saline for an in vitro osteoclast assay.

Be the First to Write a Review!

IL-35 Fc Chimera Protein

IL-35 Fc Chimera Protein

IL-35 Fc Chimera Protein

IL-35 Fc Chimera Protein

IL-35 Fc Chimera Protein

Recombinant Human IL-35 Fc Chimera Protein, CF from R&D Systems, a Bio-Techne Brand

R&D Systems, a Bio-Techne Brand

Citations (4)

Reviews

Recombinant Human IL-35 Fc Chimera Protein, CF from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map